7-116531009-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001753.5(CAV1):​c.195+4320T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.55 in 152,078 control chromosomes in the GnomAD database, including 24,750 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.55 ( 24750 hom., cov: 32)

Consequence

CAV1
NM_001753.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.228

Publications

13 publications found
Variant links:
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pulmonary hypertension, primary, 3
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital generalized lipodystrophy type 3
    Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Berardinelli-Seip congenital lipodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.913 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAV1NM_001753.5 linkc.195+4320T>G intron_variant Intron 2 of 2 ENST00000341049.7 NP_001744.2
CAV1NM_001172895.1 linkc.102+4320T>G intron_variant Intron 2 of 2 NP_001166366.1
CAV1NM_001172896.2 linkc.102+4320T>G intron_variant Intron 1 of 1 NP_001166367.1
CAV1NM_001172897.2 linkc.102+4320T>G intron_variant Intron 2 of 2 NP_001166368.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAV1ENST00000341049.7 linkc.195+4320T>G intron_variant Intron 2 of 2 1 NM_001753.5 ENSP00000339191.2

Frequencies

GnomAD3 genomes
AF:
0.550
AC:
83540
AN:
151960
Hom.:
24726
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.345
Gnomad AMI
AF:
0.473
Gnomad AMR
AF:
0.639
Gnomad ASJ
AF:
0.518
Gnomad EAS
AF:
0.935
Gnomad SAS
AF:
0.662
Gnomad FIN
AF:
0.751
Gnomad MID
AF:
0.462
Gnomad NFE
AF:
0.589
Gnomad OTH
AF:
0.530
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.550
AC:
83608
AN:
152078
Hom.:
24750
Cov.:
32
AF XY:
0.563
AC XY:
41872
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.345
AC:
14309
AN:
41474
American (AMR)
AF:
0.640
AC:
9772
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.518
AC:
1798
AN:
3470
East Asian (EAS)
AF:
0.935
AC:
4839
AN:
5176
South Asian (SAS)
AF:
0.662
AC:
3193
AN:
4824
European-Finnish (FIN)
AF:
0.751
AC:
7942
AN:
10570
Middle Eastern (MID)
AF:
0.466
AC:
137
AN:
294
European-Non Finnish (NFE)
AF:
0.589
AC:
40059
AN:
67972
Other (OTH)
AF:
0.534
AC:
1129
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1767
3533
5300
7066
8833
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
716
1432
2148
2864
3580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.566
Hom.:
15107
Bravo
AF:
0.532
Asia WGS
AF:
0.777
AC:
2698
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.1
DANN
Benign
0.50
PhyloP100
-0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3779512; hg19: chr7-116171063; API